AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines
Condition(s):Glabellar LinesLast Updated:July 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Glabellar LinesLast Updated:July 28, 2023Completed
Condition(s):Acne VulgarisLast Updated:July 20, 2021Completed
Condition(s):Post-menopausal Vasomotor SymptomsLast Updated:April 4, 2023Completed
Condition(s):Atopic DermatitisLast Updated:March 10, 2022Terminated
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:June 30, 2014Completed
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:October 9, 2017Completed
Condition(s):Hypercholesterolemia; DyslipidemiasLast Updated:July 15, 2022Completed
Condition(s):Hepatitis B, ChronicLast Updated:June 22, 2012Completed
Condition(s):Type 1 Diabetes MellitusLast Updated:February 12, 2020Completed
Condition(s):Pain Due to OsteoporosisLast Updated:January 30, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.